Table 1.
Clinicopathological characteristics of patients with ASCP and PDAC.
| Variable | ASCP (n = 48) | PDAC (n = 98) |
|---|---|---|
| Age (years), mean (range) | 58 (33–83) | 59 (35–84) |
| TMB, mean (range) | 2.75 (0.5–21.7) | 3 (0–47) |
| Gender | ||
| Female | 20 (41.7%) | 40 (40.8%) |
| Male | 28 (58.3%) | 58 (59.2%) |
| Tumour stage | ||
| I | 13 (27.1%) | 13 (13.3%) |
| II | 16 (33.3%) | 28 (28.5%) |
| III | 7 (14.6%) | 14 (14.3%) |
| IV | 11 (22.9%) | 32 (32.7%) |
| Undefined | 1 (2.1%) | 11 (11.2%) |
| Tumour differentiation | ||
| High | 1 (2.1%) | 2 (2.0%) |
| Moderate | 26 (54.2%) | 59 (60.2%) |
| Low | 12 (25%) | 17 (17.3%) |
| Undefined | 9 (18.7%) | 20 (20.3%) |
| Metastasis | ||
| Lymph node | 14 (29.2%) | 27 (27.6%) |
| Vascular invasion | 9 (18.2%) | 12 (12.2%) |
| Nerve invasion | 15 (31.3%) | 37 (37.8%) |
| Distal metastasis | 15 (31.3) | 51 (52.0%) |
| CA19-9 | ||
| ≤37 | 4 (8.3) | 15 (15.3%) |
| 37–100(≤) | 4 (8.3) | 5 (5.1%) |
| 100–1000(≤) | 14 (29.2) | 37 (37.8%) |
| >1000 | 11 (22.9) | 13 (13.3%) |
| Undefined | 15 (31.3) | 28 (28.5%) |
| Family history of cancer | ||
| Yes | 12 (25) | 23 (23.5%) |
| No | 33 (68.7) | 62 (63.2%) |
| Undefined | 3 (6.3) | 13 (13.3%) |